Intuitive Surgical has received FDA clearance for cardiac procedures using the da Vinci 5 surgical robot, according to a Jan. 26 report from Mass Device.
The new cardiac clearances cover mitral valve repair, internal mammary artery mobilization for cardiac revascularization, patent foramen ovale closure, atrial septal defect repair, left atrial appendage closure/occlusion, atrial myxoma excision, mitral valve replacement, tricuspid valve repair and epicardial pacing lead placement.
Intuitive’s portfolio of non-Force Feedback instruments all earned initial FDA approvals. The company will also look to receive cardiac clearances for its Force Feedback portfolio.
Surgeons used the da Vinci system for about 17,000 cardiac procedures worldwide in 2025, according to Intuitive Surgical’s CFO Jamie Samath.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
